AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database

E. Tanaka; E. Inoue; D. Hoshi; A. Kobayashi; N. Sugimoto; K. Shidara; E. Sato; Y. Seto; A. Nakajima; S. Momohara; A. Taniguchi; H. Yamanaka

doi:10.1136/annrheumdis-2012-eular.528

Article info

Scientific Abstracts

Abstracts accepted for publication

Rheumatoid arthritis – other biologic treatment

AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database

Authors

E. Tanaka Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
E. Inoue Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
D. Hoshi Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
A. Kobayashi Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
N. Sugimoto Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
K. Shidara Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
E. Sato Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
Y. Seto Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
A. Nakajima Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
S. Momohara Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
A. Taniguchi Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles
H. Yamanaka Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articles Google scholar articles

Citation

Tanaka E, Inoue E, Hoshi D, et al

AB0528 Cost-effectiveness of a humanized anti-interleukin-6 (IL-6) receptor monoclonal antibody, tocilizumab, in rheumatoid arthritis using IORRA cohort database

Annals of the Rheumatic Diseases 2013;71:668.

Publication history

First published January 23, 2014.

Online issue publication

April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password